FMP
NASDAQ
6.79 USD
0.02 (0.295%)
Dr. Linda Marbán Ph.D.
Healthcare
Biotechnology
https://www.capricor.com
NASDAQ
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Phase II clinical trial for the treatment of cytokine storm associated with SARS-CoV-2. The company also develops CAP-2003 that is in pre-clinical development for the treatment of trauma related injuries and conditions; and two vaccine candidates, whic...
0001133869
US14070B3096
14070B309
10865 Road to the Cure
310 358 3200
US
101
Feb 13, 2007
0001133869
NASDAQ
Biotechnology
Healthcare
14070B309
US14070B3096
US
6.79
3.96
276.65k
213.2M
-
2.68-8.22
-0.17
-
-
-
-
-8.18
-
https://www.capricor.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.